Novartis Buys U.S. Sickle Cell Drugmaker Selexys
Novartis is buying U.S.based Selexys Pharmaceuticals in a deal worth up to $665 million, the Swiss drugmaker said on Monday,...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.